Ozempic, already central in type 2 diabetes, has expanded with a new chronic kidney disease (CKD) label, reinforcing its role across the cardio-renal-metabolic spectrum. Wegovy Market Set to Expand as Obesity Treatment Demand Surges and GLP-1 Innovat The global Wegovy market is estimated to be valued at USD 10.96 Bn in 2025 and is expected to reach USD 31.51 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 16.3% from 2025 to 2032
Surgical type considerations: Retinal detachment repair (BPC-157 plus Thymosin Beta-4 aggressive protocol), Cataract surgery (Thymosin Beta-4 for corneal healing), Glaucoma filtering surgery (avoid BPC-157 potentially promoting excessive scarring, use Cerebrolysin for neuroprotection), LASIK/PRK (Thymosin Beta-4 for epithelial healing)
Discontinuing GLP-1 RA leaves our patients unsupported in their battle against the inevitable weight regain that occurs as a consequence of physiological forces, such as an increase in appetite and reduction in metabolic rate
Detoxifies the Body: One of the significant functions of glutathione is its role as an antioxidant, which can act as a reducing agent and interact with other molecules to remove them
It has a relatively short half-life, which contributes to its safety profile by mimicking the bodys natural, pulsatile release of GH rather than creating a constant, unnatural elevation
